NRX Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NRXP, updated each market day.
NRXP AI Sentiment
AI sees no strong directional signal for NRX Pharmaceuticals, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About NRX Pharmaceuticals, Inc. Common Stock
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Sector
Exchange
Market Cap
$93,912,069
Cap Tier
Employees
29
Headquarters
WILMINGTON, DE
Listed Since
May 25, 2021
Website
NRXP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NRXP Volatility
NRX Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
